Publications by authors named "A Marcoccia"
Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis.
Chest
October 2024
Background: The 2022 European Society of Cardiology/European Respiratory Society guidelines define pulmonary hypertension (PH) as a resting mean pulmonary artery pressure (mPAP) > 20 mm Hg at right heart catheterization (RHC). Previously, patients with an mPAP between 21 and 24 mm Hg were classified in a "gray zone" of unclear clinical significance.
Research Question: What is the diagnostic performance of the main parameters used for PH screening in detecting patients with systemic sclerosis (SSc) with an mPAP of 21 to 24 mm Hg at RHC?
Study Design And Methods: Patients with SSc from the European Scleroderma Trials and Research (EUSTAR) database with available tricuspid annular plane systolic excursion (TAPSE), systolic PAP (sPAP), and mPAP data were included.
Telemedicine is increasingly used in several fields of healthcare, including vascular medicine. This study aimed to investigate the views of experts and propose clinical practice recommendations on the possible applications of telemedicine in vascular medicine. A clinical guidance group proposed a set of 67 clinical practice recommendations based on the synthesis of current evidence and expert opinion.
View Article and Find Full Text PDFArticle Synopsis
- * Differences between men and women in biology and society can affect health, how doctors diagnose problems, and how patients get treated.
- * Many women don’t understand their own risk for heart problems, so it's important to raise awareness and improve medical care for women dealing with these diseases.
Objective: This study aimed to investigate the presence of psychopathological symptoms and the relations of these dimensions with the quality of life and sexual function in a group of women affected by systemic scleroderma.
Subjects And Methods: Seventy-one women with systemic scleroderma were invited to participate in the study; 65 agreed to participate, while 6 declined. Four questionnaires were administered to the patients: a specific socio-demographic questionnaire, the Symptom Checklist-90-Revised (SCL-90-R), the Female Sexual Function Index (FSFI), and the Quality-of-Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41).
Article Synopsis
- Buerger's disease (BD) is a serious condition that requires early diagnosis for effective treatment, but there’s no universally accepted method for diagnosing it due to varied criteria used by different vascular centers.
- A recent Delphi Consensus Study highlighted the lack of consensus on BD diagnostic criteria, particularly beyond the requirement of a history of smoking, making it hard to compare patient outcomes globally.
- The VAS-European Independent Foundation has proposed that a definitive BD diagnosis should include a history of smoking, typical angiographic and histopathological features, and suggests using a combination of major and minor criteria for suspected diagnoses, with validation studies currently in progress.